No Data
No Data
Surmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share Price
Here's Why You Should Hold Surmodics (SRDX) Stock for Now
Surmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
Surmodics Is Maintained at Outperform by Barrington Research
Surmodics Is Maintained at Outperform by Barrington Research
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)
No Data